|
Course Information
|
Back to Catalog
|
This lesson is supported by:
|
by Alexandra Hilts, Pharm.D., BCPS
Alexandra Hilts, Pharm.D., BCPS is a clinical infectious diseases pharmacy specialist at the University of Colorado Hospital and has an appointment as an adjoint assistant professor at the School of Pharmacy, UCHSC. Alexandra received her doctor of pharmacy degree from the University of Colorado Health Sciences Center and went on to an infectious diseases specialty residency at the University of California, San Francisco. Alexandra is also the president of the consulting company IDRx Consultants LLC. This company is involved in providing local and national training for Pharmaceutical Company Representatives primarily in the therapeutic areas of infectious diseases and oncology.
Faculty Disclosure
All faculty participating in the continuing pharmacy education activities sponsored by RxSchool are expected to disclose to participants any real or apparent conflicts of interest related to the content of their presentations. They are also expected to disclose any investigational or unlabeled uses of products discussed.
Goals and Objectives
Program Goal:
To understand the implications of the increasing instance of community acquired MRSA and the potential treatment options available to treat these infections.
Learning Objectives: At the conclusion of this program, participants should be able to:
- Acknowledge the increasing problem of multi drug resistance in Streptococcus pneumoniae
- Become more aware of the over - use of antibiotics for URIs and the damage caused by this action
- Discuss the virulence of Staphylococcus aureus
- Outline the mechanism of methicillin resistance in Staphylococcus aureus
- Recognize the risk factors of hospital – acquired MRSA (HA- MRSA)
- Acknowledge the increasing incidence of community – acquired MRSA (CA- MRSA)
- Define CA- MRSA
- Compare and contrast the risk factors of CA- MRSA with HA- MRSA
- Discuss the genetic differences between CA- MRSA and HA- MRSA
- Acknowledge the role of skin and soft tissue infection in CA- MRSA
- Recognize the potential for CA- GISA or VRSA
- Discuss the treatment options for CA – MRSA
- Note the agents in the pipeline for MRSA
Target Audience
This program is appropriate for pharmacists
|
|
|
|
|
|
|
Technologies Used
|
|
|
 Macromedia Flash
 Streaming Media
|
|
|
|
Price: FREE!
|
|
ACPE Accreditation
|
|
RxSchool is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This home study web activity has been assigned a maximum of 1 credit hours (0.1 CEU) and the ACPE UPN: 372-000-04-002-H01.
Expiration Date: 03/11/2007
Release Date: 03/11/2004
|
| |
To receive educational credit, participants must complete an online evaluation form and pass the online assessment with a score of 70% or better. If you do not receive a minimum score of 70% or better, you are permitted 1 retake(s). After passing the assessment, you can view, print and track your statements of credit online. There is no fee to participate in this activity.
|
|
|
The material presented here does not reflect the views of Pharmacy Choice, Inc., RxSchool, or the companies providing educational content. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.
|
This lesson is supported by:
|
|
|
